Evgen Pharma Share Discussion Threads

[moneymunch] 07/4/2021 18:39

Anytime soon On target, and the accumulation of cheap shares continues in anticipation. Gl :-)

[on target] 07/4/2021 18:02

More meaty trades reported after the bell.

Can't be much longer until this shareprice breaks free of its reins?

[andymunchkin] 07/4/2021 15:45

Professor_Peaky14 Feb '21 - 21:23 - 19 of 625
0 3 0
Dear Shoddy, i hear you are shorting this?

HodHasharon14 Feb '21 - 21:27 - 20 of 625
0 0 1
Only a fool would short EVG.

You shorting it Peaky?

Professor_Kemche14 Feb '21 - 21:31 - 21 of 625
0 0 0
Id happily short your mum tho

[dutch123] 07/4/2021 13:43

could be that evgen is being looked at by big pharmas, maybe crossing the T's and dotting the i's, looks like a game changer imho.

[dutch123] 07/4/2021 10:08

08.49 added. can't beat cheap broccoli..

[bumpa33] 07/4/2021 08:57

Well done Walbrook, better late than never...

[bocker01] 07/4/2021 08:53

Interesting that the company issued no caveats or cautionary interpretation in the rns.

[moneymunch] 07/4/2021 08:34

Lol...well the sanctimoniuos self righteous know it all is on record that SFX-01 will never be approved for Covid/ARDS and one of his last posts on the old thread is a classic, and probably encouraged the weak and worried to sell their shares sub 8p, makes you wonder what his and his lab assistant motives were in closing down the old thread!!!??? . ;-)

Nobbygnome - 14 Feb 2021 - 13:53:19 - 7222 of 7271

And just to say I will be posting later today on the Guild thread precisely why I think SFX-01 has little chance of working in SARS and why it didn't work in the SAH trial. However, I stress I think it stands a good chance of working in oncology inidications and other indications such as ME.

[moneymunch] 07/4/2021 08:28

Evgen Pharma: Johns Hopkins research further assesses the potential of company's drug to treat COVID-19

Scientists found that sulforaphane, the active ingredient in the company’s multi-purpose treatment, SFX-01, prevents virus-induced cell death sparked by variants of the SARS-CoV-2 virus and another unnamed coronavirus

Work carried out by researchers at the world-famous Johns Hopkins in the US appears to underline the potential of Evgen Pharma PLC’s (LON:EVG) lead drug in battling Coronavirus (COVID-19).

Researchers found that sulforaphane, the active ingredient in the company’s multi-purpose treatment, SFX-01, prevents virus-induced cell death sparked by variants of the SARS-CoV-2 virus and another unnamed Coronavirus.

In addition, the Johns Hopkins team went on to demonstrate the drug inhibited toxicity to cells as a pre-treatment before inoculation while also acting “synergistically” with antiviral drug remdesivir.

Results from the lab-based work formed the basis of a recent pre-print publication that was released before it was peer-reviewed “given the urgency of the current pandemic”.

SFX-01 is being administered to treat people with severe COVID in the STAR clinical trial being carried out by scientists at Dundee University.

An interim analysis of the first hundred patients in the STAR study is expected sometime this quarter.

Of the Johns Hopkins update, Evgen chief executive, Huw Jones, said: “If the data continue to demonstrate efficacy after peer review, they underpin and support the hypothesis we are testing with the University of Dundee in the STAR COVID-19 clinical study.”

[bumpa33] 07/4/2021 08:28

funny - two weeks since any comment on the Guild thread, and just that idiot on the short thread.

I’d have thought if one were genuinely interested in EVG the guild thread would be humming?

Or maybe they were never really that interested and should’ve just set up another “We love SNG” thread instead.

[bumpa33] 07/4/2021 08:21

Good to see the company think this is sufficiently significant to RNS, sure the share price will get traded, but I’d hope the time to trade is drawing to a close.

[moneymunch] 07/4/2021 08:19

We just need the short term profit takers mopped UP now. Gla ;-)

[chesty1] 07/4/2021 08:19

HodHasharon7 Apr '21 - 07:19 - 608 of 614
0 1 0
Feels very similar to the early SNG days! Imagine peaking at 100p today......

And for today’s stupid post!!!!

[moneymunch] 07/4/2021 08:17

Lol, yep although it will be transformational UPside profit that he'll really want, which will be a reality on positive efficacy data from SFX-01's Covid/ARDS trial. Gl ;-)

ps No doubt plenty of regrets from the pi's who were selling their shares sub 8p!!!???

[riggerbeautz] 07/4/2021 08:09

Bumpa should be on commission.

[moneymunch] 07/4/2021 08:05

On and UP!!! Gla ;-)

[amaretto1] 07/4/2021 07:45

Very good RNS EVG MXC also worth a look.

[garth] 07/4/2021 07:28

Having taken up my rights plus extras I'll settle for 10p, 15p etc etc. Good RNS.G.

[moneymunch] 07/4/2021 07:28

That would be amazing HH, but we probably need positive efficacy data from Prof Chalmers for such a rise.....but back to double figures would be very nice and more than fair value given Evgen's multiple prospects and potential, let alone the stunning endoresment on SFX-01's chances of success from John Hopkins University. Gl ;-)

[nico115] 07/4/2021 07:27

Decent rns evg Should touch 10p today on that

[hodhasharon] 07/4/2021 07:19

Feels very similar to the early SNG days! Imagine peaking at 100p today......